Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti

Targeting TREM1 augments antitumor T cell immunity by inhibiting myeloid-derived suppressor cells and restraining anti–PD-1 resistance

Published:2023-11-01 Issue:21 Volume:133 Page:
ISSN:1558-8238
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:

Author:

Ajith Ashwin^ORCID,Mamouni Kenza,Horuzsko Daniel D.,Musa Abu^ORCID,Dzutsev Amiran K.^ORCID,Fang Jennifer R.^ORCID,Chadli Ahmed,Zhu Xingguo^ORCID,Lebedyeva Iryna,Trinchieri Giorgio^ORCID,Horuzsko Anatolij^ORCID

Funder

NIH/NCI

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://www.jci.org/articles/view/167951/files/pdf

Reference89 articles.

1. Cutting Edge: Inflammatory Responses Can Be Triggered by TREM-1, a Novel Receptor Expressed on Neutrophils and Monocytes

2. The biology of TREM receptors

3. TREM-1 amplifies inflammation and is a crucial mediator of septic shock

4. TREM-1 and its potential ligands in non-infectious diseases: from biology to clinical perspectives

5. Chronic inflammation and cancer: emerging roles of triggering receptors expressed on myeloid cells

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting myeloid-derived suppressor cells promotes antiparasitic T-cell immunity and enhances the efficacy of PD-1 blockade;Nature Communications;2024-07-27

2. Defining myeloid-derived suppressor cells;Nature Reviews Immunology;2024-07-05

3. Pharmacological Inhibition or Silencing of TREM1 Restrains HCC Cell Metastasis by Inactivating TLR/PI3K/AKT Signaling;Cell Biochemistry and Biophysics;2024-07-02

4. Sex differences in glioblastoma based on tumor subtypes;Neuro-Oncology;2024-06-17

5. TREM1: Activation, signaling, cancer and therapy;Pharmacological Research;2024-06